510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K934340Substantially Equivalent

Biosite Diagnostics - Triage Panel for Drugs of Abuse Plus Tricyclic Antidepressants

Biosite Incorporated, San Diego CA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K934340 is the FDA 510(k) clearance record for BIOSITE DIAGNOSTICS - TRIAGE PANEL FOR DRUGS OF ABUSE PLUS TRICYCLIC ANTIDEPRESSANTS, a class II device, cleared for Biosite Incorporated on under FDA product code LFI (High Pressure Liquid Chromatography, Tricyclic Antidepressant Drugs). FDA records list 46 510(k) clearances for Biosite Incorporated, from to . As of , FDA records show no recalls naming K934340.

Clearance record

Decision date
Received
(450 days to decision)
Product code
LFI High Pressure Liquid Chromatography, Tricyclic Antidepressant Drugs
Regulation
21 CFR 862.3910
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Biosite Incorporated 11030 Roselle St., San Diego CA
510(k) summary
Statement
Third party review
No

Clearances, product code LFI

Trailing 12 months

FDA records hold no clearances under product code LFI in the trailing twelve months.

FDA records show no clearances under product code LFI in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code LFI, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260